How could the ongoing investigation into the use of GLP-1 agonists for Type 1 diabetes shape future treatment options, and what ethical considerations might arise from prescribing these medications off-label
compared to placebo, the mean attack rate was 81% lower (95% confidence interval [CI], 65 to 89
For broader condition browsing, the Anxiety and Depression sections group related prescription and non-prescription health products by condition
Ongoing research continues to explore Berberines potential therapeutic benefits in treating metabolic, cardiovascular, and inflammatory disorders
It has gained significant attention for its profound effects on connective tissue healing
Sin embargo, dependiendo de la composicin de la microbiota intestinal, el riesgo de tener un evento adverso cardiovascular puede ser menor en individuos con TMAO circulante bajo versus alto, incluso aunque las concentraciones de colina y/o betana en la sangre estn elevadas (115)